ExoLabz logo
support@exolabz.ca
Vortexing, Sonication and Shear: The Cost of Making It Dissolve

Vortexing, Sonication and Shear: The Cost of Making It Dissolve

A peptide will not dissolve, so the vial goes on the vortex mixer. It still will not dissolve, so it goes in the sonicator bath. Something eventually goes into solution, and whether it is still the same molecule is a question nobody asks, because the outcome looked like success.

What vortexing actually does to a solution

Vortexing generates shear at the liquid boundary and, more importantly, creates a large and constantly renewed air-liquid interface. That interface is the part that matters.

A peptide molecule at an air-water boundary orients with its hydrophobic residues toward the air and its polar residues toward the water. This is energetically favourable, it partially unfolds the molecule, and unfolded molecules at an interface are in an excellent position to associate with each other. Sustained vortexing therefore promotes exactly the behaviour described in peptide aggregation in solution, and it does so most efficiently in the sequences already prone to it.

Foaming is the visible version of the same thing. A solution that foams has made an enormous amount of interface, and foam that persists after the mixer stops is a sign that something surface-active is stabilising it — often the peptide itself.

Sonication is not gentle

Ultrasound in a liquid produces cavitation: microscopic bubbles that form and collapse. The collapse is violent and local, and the conditions inside a collapsing bubble are extreme — very high transient temperature and pressure in a volume too small to register on a thermometer.

Three consequences follow, none of which are visible:

  • Radical generation. Cavitation splits water into hydroxyl and hydrogen radicals. These oxidise methionine, cysteine and tryptophan readily, producing exactly the modifications covered in oxidation and related impurities.
  • Local heating. A bath warms measurably over a long run, and the bulk temperature understates what the molecule experiences near a collapsing bubble.
  • Mechanical fragmentation. Long chains are more vulnerable than short ones, and disulfide bonds can be reduced or scrambled under radical conditions, in the way set out in disulfide formation and scrambling.

A probe sonicator delivers far more energy into a far smaller volume than a bath does and is correspondingly worse for this purpose.

Why the material dissolves anyway

This is the trap. Agitation does often produce a clear solution, and clarity is read as success. But a clear solution can be reached two ways: the solid dissolved, or the solid was broken into fragments small enough to stay suspended and to no longer scatter visible light.

Aggregated material that has been sheared into sub-visible particles is a clear solution containing aggregates. It will pass a visual inspection, it will pass through a filter, and it will be measured as if it were monomeric. The method that would detect the difference is the native-condition one described in size exclusion and aggregate detection, and it is not run.

What to do instead when something will not dissolve

Insolubility is a chemistry problem and agitation is a mechanical answer to it, which is why more agitation rarely helps. The productive responses address the chemistry:

  • Wait. Wet the material and leave it. Many peptides that appear insoluble at two minutes are in solution at fifteen with no intervention at all.
  • Change the pH. Solubility is lowest near the isoelectric point and rises in both directions from it. Moving a unit or two either way is usually more effective than any amount of mixing, per isoelectric point and solubility.
  • Change the solvent. A small volume of a stronger solvent to dissolve, followed by dilution into the working buffer, succeeds where the working buffer alone does not — the sequence discussed in choosing a reconstitution solvent.
  • Warm it slightly, briefly. Gentle warming to around thirty degrees for a few minutes is a smaller insult than sonication, though it is not free either.

The mixing that is actually appropriate

Inversion and rolling. Turning the closed vial end over end a dozen times mixes the contents thoroughly while creating almost no new interface, because the air bubble travels through the liquid rather than being whipped into it. Rolling on a tube roller does the same over a longer period.

Where a vortex mixer is the practical option — a viscous solution, a stubborn pellet — short bursts at low speed with rests between them are substantially less damaging than one continuous high-speed run, and the vial should be full enough that there is little headspace to foam into.

Where the stress is easy to forget

Agitation is not the only mechanical insult in a workflow. Drawing a solution rapidly through a narrow pipette tip is a shear event. Pushing it through a filter membrane is another. Pouring produces interface. Transporting a filled vial across a building on a trolley is hours of low-level agitation, which is why shipping stress is a recognised category in a stability protocol.

None of these individually does much. The point is that they accumulate on the same molecules, in a sample that may already have been through several freeze-thaw cycles of the kind described in freeze-thaw cycles — including the ones nobody scheduled, discussed in freezer choice and the auto-defrost cycle.

What this does not mean

It does not mean a vortex mixer is forbidden, or that a peptide vortexed for five seconds is compromised. Robust sequences tolerate a great deal, and the majority of short synthetic peptides are robust.

What it means is that agitation is an intervention with a cost, and the cost falls hardest on the material least able to bear it — long chains, disulfide-containing sequences, and anything aggregation-prone. Treating gentleness as the default and agitation as the exception costs nothing when the peptide is robust and preserves the sample when it is not.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Legal Disclaimer

The products offered by ExoLabz are intended solely for research purposes. These products are not for human consumption, are not intended for medical use, and have not been approved by the FDA or Health Canada for any therapeutic or diagnostic purpose. ExoLabz makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment. By purchasing our products, you agree to use them strictly for scientific research and in compliance with all local laws and regulations.

GLP-1 15mg research peptide vial - ExoLabz Canada
0
    0
    Your Cart
    Your cart is empty